Posted by Clinical Lab Products | Jul 20, 2010 | Miscellaneous |
The FDA can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way, according to the American Clinical Laboratory Association.
Read MorePosted by Clinical Lab Products | Jul 14, 2010 | Miscellaneous |
Asuragen Inc and Life Technologies Corp announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test.
Read MorePosted by Clinical Lab Products | Jul 9, 2010 | Cancer, Miscellaneous |
Researchers at Whitehead Institute and Childrens Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Read MorePosted by Clinical Lab Products | Jun 9, 2010 | Miscellaneous |
Biomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read MorePosted by Clinical Lab Products | Apr 22, 2010 | Cancer, Miscellaneous |
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read More